Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Karuna Therapeutics
Pharma
BMS partner Zai Lab eyes China filing for KarXT after trial win
Following a China-based schizophrenia trial win, Bristol Myers partner Zai Lab is moving fast to expand the global reach of novel antipsychotic KarXT.
Fraiser Kansteiner
Oct 29, 2024 1:59pm
BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap
Oct 7, 2024 3:00am
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
BMS' dealmaking appetite remains intact, CEO says
Jun 12, 2024 10:55am
Alkermes reports strong trajectory for Lybalvi, shares up 10%
Feb 15, 2024 1:10pm
‘The Top Line’: The most anticipated drug launches of 2024
Feb 9, 2024 6:00am
